Consolidated Statements of Stockholders’ Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 14	$ 190,529	$ 93,778,591	$ (92,266,764)	$ 1,702,369
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted stock		$ 31	4,519		4,550
RSU restricted stock (in Shares)		31,250
Stock-based compensation			1,232,256		1,232,256
Common stock issued on cashless exercise of options and warrants		$ 4,084	(4,084)
Common stock issued on cashless exercise of options and warrants (in Shares)		4,082,637
Common stock issued on exercise of options and warrants		$ 1,650	106,350		108,000
Common stock issued on exercise of options and warrants (in Shares)		1,650,010
Common stock issued on exercised of convertible note		$ 158	473,404		47,498
Common stock issued on exercised of convertible note (in Shares)		158,329
Sale of common stock		$ 11,110	5,287,890		5,299,000
Sale of common stock (in Shares)		11,110,915
Net loss			(5,425,453)		(5,425,453)
Balance at Dec. 31, 2021	$ 14	$ 207,562	100,452,862	(97,692,217)	2,968,221
Balance (in Shares) at Dec. 31, 2021	13,602	207,562,461
RSU restricted stock		$ 131	(131)
RSU restricted stock (in Shares)		130,417
Stock-based compensation			1,776,140		1,776,140
Common stock issued on exercise of options and warrants		$ 162	18,907		19,069
Common stock issued on exercise of options and warrants (in Shares)		162,066
Sale of common stock		$ 2,994	6,583,204		6,586,198
Sale of common stock (in Shares)		2,993,727
Net loss				(5,771,642)	(5,771,642)
Balance at Dec. 31, 2022	$ 14	$ 210,849	$ 108,830,982	$ (103,463,859)	$ 5,577,986
Balance (in Shares) at Dec. 31, 2022	13,602	210,848,671